U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188941188941Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)CompletedNo Results AvailableAcute Coronary SyndromeDrug: Enoxaparin sodiumhttps://ClinicalTrials.gov/show/NCT00077818
188942188942PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)CompletedNo Results AvailableAcute Ischemic StrokeDrug: Enoxaparin sodiumhttps://ClinicalTrials.gov/show/NCT00077805
188943188943Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)CompletedNo Results AvailableMyocardial Infarction|Acute ST-Segment ElevationDrug: Enoxaparin sodium (XRP4563)https://ClinicalTrials.gov/show/NCT00077792
188944188944Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: Adalimumabhttps://ClinicalTrials.gov/show/NCT00077779
188945188945A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.CompletedNo Results AvailableAnemiaDrug: Darbepoetin alfa|Drug: methoxy polyethylene glycol-epoetin beta [Mircera]https://ClinicalTrials.gov/show/NCT00077766
188946188946EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged ImmobilizationCompletedNo Results AvailableVenous ThromboembolismDrug: enoxaparin sodiumhttps://ClinicalTrials.gov/show/NCT00077753
188947188947A Study of the Effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment in Patients With Schizophrenia.CompletedNo Results AvailableSchizophreniaDrug: Extended-release galantamine hydrobromidehttps://ClinicalTrials.gov/show/NCT00077727
188948188948Trial Evaluating the Efficacy and Safety of 2 Fixed Doses of Paliperidone Extended-Release (ER) Tablets in the Treatment of Adult Patients With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Paliperidone ERhttps://ClinicalTrials.gov/show/NCT00077714
188949188949TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced Unresectable Transitional Cell Carcinoma of the UrotheliumCompletedNo Results AvailableBladder Neoplasms|Ureteral Neoplasms|Urethral Neoplasms|Carcinoma, Transitional CellDrug: TOCOSOL Paclitaxelhttps://ClinicalTrials.gov/show/NCT00077688
188950188950Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)CompletedHas ResultsInfections, Gram-Positive BacterialDrug: Telavancin|Drug: vancomycin or antistaphylococcal penicillinhttps://ClinicalTrials.gov/show/NCT00077675
188951188951A Prospective, Observational Study in Patients With Late-Onset Pompe DiseaseCompletedNo Results AvailableGlycogen Storage Disease Type IIhttps://ClinicalTrials.gov/show/NCT00077662
188952188952A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).CompletedNo Results AvailableHepatitis C, ChronicDrug: Copegus|Drug: Copegus|Drug: peginterferon alfa-2a [Pegasys]|Drug: peginterferon alfa-2a [Pegasys]https://ClinicalTrials.gov/show/NCT00077649
188953188953ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.CompletedNo Results AvailableHepatitis C, ChronicDrug: Copegus|Drug: Copegus|Drug: peginterferon alfa-2a [Pegasys]|Drug: peginterferon alfa-2a [Pegasys]https://ClinicalTrials.gov/show/NCT00077636
188954188954A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.CompletedNo Results AvailableAnemiaDrug: epoetin alfa or beta|Drug: methoxy polyethylene glycol-epoetin beta [Mircera]|Drug: methoxy polyethylene glycol-epoetin beta [Mircera]https://ClinicalTrials.gov/show/NCT00077623
188955188955A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis PatientsCompletedNo Results AvailableAnemiaDrug: epoetin alfa or beta|Drug: methoxy polyethylene glycol-epoetin beta [Mircera]|Drug: methoxy polyethylene-glycol epoetin beta [Mircera]https://ClinicalTrials.gov/show/NCT00077610
188956188956A Study of Mircera for the Treatment of Anemia in Dialysis PatientsCompletedNo Results AvailableAnemiaDrug: epoetin|Drug: methoxy polyethylene glycol-epoetin beta [Mircera]https://ClinicalTrials.gov/show/NCT00077597
188957188957Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Scleroderma PatientsCompletedNo Results AvailableSystemic Sclerosis|SclerodermaDrug: Bosentanhttps://ClinicalTrials.gov/show/NCT00077584
1889581889583-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic SyndromeCompletedNo Results AvailableLeukemia|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative DiseasesDrug: fludarabine phosphate|Drug: triapinehttps://ClinicalTrials.gov/show/NCT00077558
1889591889593-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal JunctionCompletedNo Results AvailableAdenocarcinoma of the Esophagus|Recurrent Esophageal Cancer|Stage IV Esophageal CancerDrug: triapine|Drug: cisplatinhttps://ClinicalTrials.gov/show/NCT00077545
188960188960Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: gp100 antigen|Biological: incomplete Freund's adjuvant|Biological: ipilimumabhttps://ClinicalTrials.gov/show/NCT00077532
188961188961Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic CancerActive, not recruitingNo Results AvailablePancreatic CancerDrug: tipifarnib|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00077519
188962188962BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's LymphomaSuspendedNo Results AvailableLeukemia|LymphomaDrug: BL22 immunotoxin|Procedure: antibody-drug conjugate therapy|Procedure: immunotoxin therapy|Procedure: monoclonal antibody therapyhttps://ClinicalTrials.gov/show/NCT00077493
188963188963Bortezomib in Treating Young Patients With Refractory or Recurrent LeukemiaCompletedNo Results AvailableBlastic Phase Chronic Myelogenous Leukemia|Childhood Acute Promyelocytic Leukemia (M3)|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid LeukemiaDrug: bortezomib|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00077467
188964188964Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsCompletedNo Results AvailablePreviously Treated Childhood Rhabdomyosarcoma|Recurrent Childhood Brain Tumor|Recurrent Childhood Cerebellar Astrocytoma|Recurrent Childhood Cerebral Astrocytoma|Recurrent Childhood Ependymoma|Recurrent Childhood Malignant Germ Cell Tumor|Recurrent ChildhDrug: erlotinib hydrochloride|Drug: temozolomide|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00077454
188965188965Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)CompletedNo Results AvailableAdult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver CancerDrug: bortezomib|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00077441
188966188966Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and NeckCompletedNo Results AvailableRecurrent Adenoid Cystic Carcinoma of the Oral Cavity|Recurrent Salivary Gland Cancer|Salivary Gland Adenoid Cystic Carcinoma|Stage III Adenoid Cystic Carcinoma of the Oral Cavity|Stage III Salivary Gland Cancer|Stage IV Adenoid Cystic Carcinoma of the OrDrug: bortezomib|Drug: doxorubicin hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00077428
1889671889673-AP and Gemcitabine as Second-Line Therapy in Treating Patients With Stage III or Stage IV Recurrent Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: gemcitabine hydrochloride|Drug: triapinehttps://ClinicalTrials.gov/show/NCT00077415
188968188968Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate CancerCompletedNo Results AvailableProstate CancerDrug: fenretinidehttps://ClinicalTrials.gov/show/NCT00077402
188969188969Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk HepatoblastomaActive, not recruitingNo Results AvailableLiver CancerDrug: carboplatin|Drug: cisplatin|Drug: doxorubicin hydrochloride|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00077389
188970188970Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast CancerCompletedHas ResultsHER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast CancerBiological: trastuzumab|Drug: ixabepilone|Drug: carboplatin|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00077376

* Görseller ve İçerik tekif hakkına sahip olabilir